Corona virus causes severe contagious acute respiratory syndrome known as coronavirus disease 2019 (COVID-19). Several initiatives have been taken to tackle so far. One of them, being therapy based biological nano particles “Exosomes”. Administration exosomes loaded with immunomodulatory cargo in combination antiviral drugs will be a promising approach. This study deals the exosomal isolation t...


 CADTH recommends that Brukinsa be reimbursed by public drug plans for the treatment of adult patients with chronic lymphocytic leukemia (CLL) if certain conditions are met.
 should only covered to treat previously untreated CLL whom fludarabine-based is inappropriate or relapsed refractory (r/r) who have received at least 1 prior systemic therapy. Patients receiving in relatively go...